ResMed - 23 Year Stock Price History | RMD

Historical daily share price chart and data for ResMed since 1995 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for ResMed as of November 15, 2018 is 104.23.
ResMed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 101.9344 84.6130 115.5500 84.6130 104.2300 24.41%
2017 73.5447 60.1489 85.5132 60.0712 83.7820 39.07%
2016 58.5286 49.6416 67.9001 48.8714 60.2460 18.02%
2015 55.9630 53.2843 70.0408 46.7548 51.0488 -2.30%
2014 45.6304 42.1592 53.4893 38.3539 52.2497 21.62%
2013 43.1829 38.1020 51.8610 38.1020 42.9623 15.22%
2012 30.5781 22.7705 38.3621 22.0592 37.2858 65.10%
2011 26.7604 31.1372 31.3684 20.8589 22.5838 -26.67%
2010 27.8984 23.4685 31.6618 22.4727 30.7993 32.54%
2009 18.8166 17.0623 23.5930 14.1460 23.2373 39.46%
2008 17.9791 22.8105 22.8105 13.2613 16.6622 -28.65%
2007 20.1763 22.2593 24.1220 17.6269 23.3529 6.72%
2006 19.3299 16.9912 22.7083 16.3866 21.8814 28.48%
2005 14.8314 11.2941 18.9917 11.0718 17.0312 49.94%
2004 10.5616 9.3358 11.4608 9.0446 11.3586 23.01%
2003 8.5156 6.9018 10.3339 6.5951 9.2336 35.89%
2002 7.4442 11.8143 11.8143 5.4904 6.7951 -43.31%
2001 11.1249 8.7534 13.7259 8.1488 11.9854 35.21%
2000 6.8685 4.5434 9.2247 4.5223 8.8646 91.04%
1999 3.7102 4.7513 5.7171 2.1950 4.6401 -8.00%
1998 2.5000 1.5560 5.2514 1.5560 5.0436 222.77%
1997 1.3115 1.1948 1.7227 0.9447 1.5626 27.82%
1996 0.8971 0.6668 1.2781 0.5835 1.2225 69.23%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.484B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.396B 19.07
Abbott Laboratories (ABT) United States $121.907B 24.70
Stryker (SYK) United States $62.115B 23.41
Boston Scientific (BSX) United States $50.107B 25.32
Baxter (BAX) United States $33.967B 21.93
Zimmer Biomet Holdings (ZBH) United States $22.913B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.016B 0.00
Perrigo (PRGO) Ireland $8.621B 13.09
Bio-Rad Laboratories (BIO) United States $8.038B 51.40
Canopy Growth (CGC) Canada $7.963B 0.00
Hill-Rom Holdings (HRC) United States $6.061B 19.22
Aurora Cannabis (ACB) Canada $5.941B 32.42
Haemonetics (HAE) United States $5.495B 48.32
Hutchison China MediTech (HCM) China $5.011B 0.00
Insulet (PODD) United States $4.690B 0.00
ICU Medical (ICUI) United States $4.600B 25.63
GW Pharmaceuticals (GWPH) United Kingdom $3.898B 0.00
Agios Pharmaceuticals (AGIO) United States $3.709B 0.00
National Vision Holdings (EYE) United States $3.224B 62.36
Neogen (NEOG) United States $3.190B 48.31
NuVasive (NUVA) United States $3.045B 28.33
Quidel (QDEL) United States $2.390B 31.16
Aphria (APHA) $2.383B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.455B 20.60
AtriCure (ATRC) United States $1.189B 0.00
Cardiovascular Systems (CSII) United States $1.007B 1450.50
VAREX IMAGING (VREX) United States $0.933B 18.74
Meridian Bioscience (VIVO) United States $0.816B 26.01
Surmodics (SRDX) United States $0.775B 118.39
OraSure Technologies (OSUR) United States $0.771B 43.38
Eagle Pharmaceuticals (EGRX) United States $0.738B 23.67
PetIQ (PETQ) United States $0.737B 20.93
MacroGenics (MGNX) United States $0.702B 0.00
Cerus (CERS) United States $0.685B 0.00
Lantheus Holdings (LNTH) United States $0.604B 18.68
Omeros (OMER) United States $0.569B 0.00
Owens & Minor (OMI) United States $0.550B 6.22
Insys Therapeutics (INSY) United States $0.531B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.05
NanoString Technologies (NSTG) United States $0.478B 0.00
TG Therapeutics (TGTX) United States $0.429B 0.00
Evolus (EOLS) United States $0.373B 0.00
Quanterix (QTRX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.11
Cytosorbents (CTSO) United States $0.287B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.254B 0.00
Rockwell Medical (RMTI) United States $0.230B 0.00
Surface Oncology (SURF) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.197B 265.75
Bovie Medical (BVX) United States $0.189B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.138B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.53
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Senestech (SNES) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00